Cleveland Biolabs Inc. Reports First Quarter 2017 Financial Results And Development Progress Post author:Sam Post published:May 15, 2017 Post category:BioPharma Life Sciences Jobs … Source: BioSpace You Might Also Like FDA's Shorten Review Time is a Bad Sign for Puma Biotech's Controversial Cancer Drug April 18, 2017 Bay Area's Ardelyx Nabs $160M Deal With Kyowa Hakko Kirin November 27, 2017 Bristol-Myers Squibb's Opdivo Prevails in Phase III Melanoma Trial July 4, 2017